Catalyst Wire Dossier Catalyst Wire Dossier

Invega ER (paliperidone extended-release)

Paliperidone · Janssen Pharmaceuticals / Johnson & Johnson
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Invega ER (paliperidone extended-release), covering 2011-06-08 to 2011-06-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Potential Effects of Trimethoprim on the Pharmacokinetics of ER OROS Paliperidone [Phase 1]

See pricing